admin

India’s healthcare and e-pharmacy space is undergoing a transformation, with PharmEasy at the forefront. Recently, the company raised ₹1,700 crore (~US$193 million) fresh debt to repay its Goldman Sachs loan, following a significant valuation reset. While some may view this as a setback, in reality, it highlights PharmEasy’s strategic restructuring and renewed focus on building … PharmEasy’s Fresh Debt Raise: A Positive Signal for Pre-IPO Investors

The National Commodity & Derivatives Exchange (NCDEX) is one of India’s premier commodity exchanges, offering trading in agricultural commodities such as soybeans, chana, and guar seed. While NCDEX operates at the heart of India’s agri-trading ecosystem, its own shares remain unlisted, creating a lucrative yet less explored opportunity for investors. Recent investments from prominent names … NCDEX Unlisted Shares: What’s Driving the Big Bets by Damani, Zerodha & Groww

Date: 25th December, 2024 Investing in Pre-IPO shares has gained significant attention among savvy investors looking for opportunities in the emerging market. By acquiring Pre-IPO shares, you can tap into high-growth companies before they go public, potentially reaping substantial rewards. However, understanding the intricacies of pre-IPO investment is crucial for making informed decisions. Here’s a … How to Invest in Pre-IPO Shares: Unlocking Opportunities in Emerging Startups

In the ever-evolving world of investments, unlisted shares have emerged as a compelling option for those seeking high-growth potential and diversification. While they remain a lesser-explored territory compared to listed stocks, investing in unlisted companies can open doors to substantial long-term returns. When evaluating unlisted securities, understanding their dynamics is essential for making well-informed and … Investing in Unlisted Shares: Unlocking Opportunities in Unlisted Companies